An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

By Gottlieb A. B.   Strober B.   Krueger J. G.   Rohane P.   Zeldis J. B.   Hu C. C.   Kipnis C.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1529-1538

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of mirabegron as ‘add‐on’ therapy in patients with overactive bladder treated with solifenacin: a post‐marketing, open‐label study in Japan (MILAI study)

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-seated Mycosis in Japan

By Kohno Shigeru   Masaoka Toru   Yamaguchi Hideyo   Mori Takeshi   Urabe Akio   Ito Akira   Niki Yoshihito   Ikemoto Hideo  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 5, 2004-05 ,pp. : 372-379

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study*

By Réa-Neto Álvaro   Niederman Michael   Margareth Lobo Suzana   Schroeder Eric   Lee Michael   Kaniga Koné   Ketter Nzeera   Prokocimer Philippe   Friedland Ian  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2113-2126

Informa Healthcare

Access to resources Recommend Favorite

An Open-Label, Multicenter Study of Outpatient Capecitabine Monotherapy in 631 Patients with Pretreated Advanced Breast Cancer

By  

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 51-57

Karger

Access to resources Recommend Favorite